Stocks · Consumer Cyclical · Specialty Retail
Petco Health and Wellness Company, Inc. WOOF
$2.18 -0.46% Close, Oct 5, 2026 · NASDAQ · Market cap $625.4M
Weak trendInexpensive vs sector
Next earnings report: Nov 24, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- At 21.8× trailing earnings, the shares trade at the lowest P/E of the company's past five years.
- Net debt is 3.5× EBITDA, a high level of leverage.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Consumer Cyclical sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 25%
- FCF growth (TTM, YoY)Top 3%
- Revenue growth, 3-year CAGRBottom 40%
- Revenue growth accelerationTop 39%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 35%
- Gross marginTop 43%
- Operating marginBottom 25%
- Cash conversion (OCF / net income)Top 12%
- Accruals (lower is better)Top 31%
- Net debt / EBITDA (lower is better)Bottom 39%
- Interest coverBottom 24%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 48%
- Free-cash-flow yieldTop 1%
- EBITDA / enterprise valueTop 5%
- Sales / enterprise valueTop 4%
- P/E vs own 5-year history (lower is better)Top 7%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 14%
- 6-month returnBottom 23%
- 1-year return vs S&P 500Bottom 13%
- Distance from 52-week highBottom 24%
- Trend checklist (0–4)Bottom 18%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 25%
- Consecutive EPS beatsBottom 33%
- Share of analysts rating BuyBottom 31%
- Upside to consensus price targetTop 14%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 44%
- Maximum drawdown, 3 yearsBottom 37%
- Beta vs S&P 500 (lower is better)Bottom 45%
- Net debt / EBITDA (lower is better)Bottom 39%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -1.9% | -1.3% | ↑ |
| Gross margin | 36.7% | 38.8% | ↑ |
| Operating margin | 1.6% | 2.2% | ↑ |
| FCF margin | 1.0% | 5.2% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -1.3% | -1.9% | ↑ | Bottom 25% |
| Gross margin | 38.8% | 36.7% | ↑ | Top 43% |
| Operating margin | 2.2% | 1.6% | ↑ | Bottom 25% |
| Net margin | 0.5% | -0.5% | ↑ | — |
| Free-cash-flow margin | 5.2% | 1.0% | ↑ | — |
| Return on invested capital | 3.3% | — | Bottom 35% | |
| Revenue growth, 3-year CAGR | -0.4% | — | Bottom 40% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -7.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +12.5 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 3.49×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 1.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.58%
- Shareholder yield
- -0.58%
- Share count change, 1 year
- +1.7%
- Share count change, 3-year CAGR
- +2.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Aug 1, 2026 (filed Sep 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +34.5%
- Average 2-day reaction, last 8
- +1.6%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $3.80
- Target vs current price
- +74.3%
- Analysts with a rating
- 25
- Share rating Buy or Strong Buy
- 40%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Sep 2, 2026 | +18.5% | +1.9% | -4.3% | -12.0% | — |
| Jun 3, 2026 | -35.1% | +3.0% | -8.1% | -8.1% | -8.4% |
| Mar 11, 2026 | -50.0% | +3.0% | +45.1% | +20.6% | +23.2% |
| Nov 25, 2025 | +204.5% | +6.5% | +12.2% | +3.6% | -11.8% |
| Aug 28, 2025 | +700.0% | +0.9% | +6.9% | +7.8% | -17.8% |
| Jun 5, 2025 | +50.0% | +1.7% | -26.1% | -13.5% | +12.1% |
| Mar 26, 2025 | -20.8% | -1.2% | +19.8% | +23.9% | +6.5% |
| Dec 5, 2024 | +50.0% | -3.0% | -2.8% | -19.6% | -49.7% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Sep 2, 2026 | $0.08 | $0.07 | +18.5% | $1.49B |
| Jun 3, 2026 | $0.01 | $0.02 | -35.1% | $1.50B |
| Mar 11, 2026 | $0.01 | $0.02 | -50.0% | $1.52B |
| Nov 25, 2025 | $0.05 | $0.02 | +204.5% | $1.46B |
| Aug 28, 2025 | $0.08 | $0.01 | +700.0% | $1.49B |
| Jun 5, 2025 | -$0.01 | -$0.02 | +50.0% | $1.49B |
| Mar 26, 2025 | $0.02 | $0.02 | -20.8% | $1.55B |
| Dec 5, 2024 | -$0.02 | -$0.04 | +50.0% | $1.51B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 21.8× | 35.1× | 0th | Top 48% |
| P/E (forward) | 8.8× | — | — | — |
| EV / EBITDA | 5.3× | — | — | Top 5% |
| EV / Sales | 0.30× | — | — | Top 4% |
| Free-cash-flow yield | 49.28% | — | — | Top 1% |
| Earnings yield | 4.58% | — | — | Top 48% |
P/E over the past five years
Range 23.7× – 151.3× since Jul 31, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -4.2%
- 200-day average slope (20 days)
- -2.4%
- Distance from 50-day average
- -16.1%
- Distance from 200-day average
- -19.9%
- RSI (14)
- 29.1
- Relative volume
- 1.17×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 44.6%
- Volatility vs own 5-year history
- 11th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.09
- Correlation with S&P 500
- 0.24
- Current drawdown from 1-year high
- -43.1%
- Maximum drawdown, 3 years
- -63.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 14, 2021 | Apr 30, 2024 | -94.9% | 827 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $625.4M
- P/E (TTM)
- 21.8
- EPS, diluted (TTM)
- $0.10
- Revenue (TTM)
- $5.97B
- 52-week range
- $2.14 – $3.96
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $5.81B | $6.04B | $6.26B | $6.12B | $5.96B |
| Gross profit | $2.43B | $2.43B | $2.35B | $2.32B | $2.31B |
| Operating income | $266.1M | $225.6M | -$1.18B | $7.1M | $120.4M |
| Net income | $164.4M | $90.8M | -$1.28B | -$101.8M | $9.1M |
| EPS (diluted) | $0.62 | $0.34 | -$4.78 | -$0.37 | $0.03 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.51B | $1.55B | $1.49B | $1.49B | $1.46B | $1.52B | $1.50B | $1.49B |
| Net income | -$16.7M | -$13.8M | -$11.7M | $14.0M | $9.3M | -$2.6M | -$15.1M | $38.7M |
| EPS (diluted) | -$0.06 | -$0.05 | -$0.04 | $0.05 | $0.03 | -$0.01 | -$0.05 | $0.13 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $358.2M | $346.0M | $215.7M | $177.7M | $314.1M |
| Capital expenditure | -$239.1M | -$278.0M | -$225.6M | -$128.0M | -$127.1M |
| Free cash flow | $119.1M | $68.0M | -$9.9M | $49.7M | $187.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $0 | $0 | $0 | $2.5M | $3.7M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $293.5M
- Total assets
- $5.17B
- Total liabilities
- $3.96B
- Total debt
- $1.48B
- Net debt
- $1.18B
- Shareholders’ equity
- $1.21B
As of Aug 1, 2026 (filed Sep 4, 2026).
Short interest
- Shares sold short
- 19,953,473
- Days to cover
- 5.01
- Change vs previous report
- +2.6%
FINRA short interest, settlement date Sep 15, 2026.